Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 7—July 2025
Research
Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992–2021
Table 1
Summary characteristics of first disseminated histoplasmosis cases among persons living with HIV from the French Hospital Database on HIV, France and overseas territories, 1993–2021*
Variable | Value |
---|---|
Median age, y (IQR) |
41.3 (33.2–48.8) |
Sex | |
M | 352 (63.7) |
F | 197 (35.6) |
Other† |
4 (0.7) |
Geographic origin | |
Mainland France | 166 (30) |
Western Europe | 1 (0.2) |
Sub-Saharan Africa | 83 (15) |
Middle East | 2 (0.3) |
Asia | 6 (1.1) |
North America | 1 (0.2) |
South and Central America | 189 (34.2) |
Caribbean |
105 (19) |
Residence | |
Mainland France | 150 (28.8) |
Martinique | 17 (3.3) |
Guadeloupe | 34 (6.5) |
French Guiana | 318 (61) |
Reunion Island |
2 (0.4) |
AIDS stage before histoplasmosis | |
Yes | 244 (44.1) |
No |
309 (55.9) |
On antiretroviral treatment before histoplasmosis | |
Yes | 56 (10.1) |
No |
497 (89.9) |
Median CD4, cells/mm3 (IQR) |
20 (6–53) |
CD4/CD8 ratio >1 at time of histoplasmosis | |
Yes | 29 (5.7) |
No |
479 (94.3) |
Median viral load at time of histoplasmosis, copies/mL (IQR) | 16,480 (485–205,000) |
*Values are no. (%) except as indicated. IQR, interquartile range †Other indicates that personal identity is discordant from birth sex.
Page created: May 14, 2025
Page updated: June 17, 2025
Page reviewed: June 17, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.